Home
Random
Log in
Settings
About HemOnc.org - A Hematology Oncology Wiki
Disclaimers
HemOnc.org - A Hematology Oncology Wiki
Search
Category
:
FDA approved in 2023
Language
Watch
View source
Pages in category "FDA approved in 2023"
The following 24 pages are in this category, out of 24 total.
A
ADAMTS13, recombinant (Adzynma)
B
Bevacizumab-tnjn (Avzivi)
C
Capivasertib (Truqap)
E
Efanesoctocog alfa (Altuviiio)
Eflornithine (Iwilfin)
Elacestrant (Orserdu)
Elranatamab (Elrexfio)
Epcoritamab (Epkinly)
Exagamglogene autotemcel (Casgevy)
F
Fruquintinib (Elunate)
G
Glofitamab (Columvi)
I
Iptacopan (Fabhalta)
M
Melphalan for Injection-Hepatic Delivery System (Hepzato Kit)
Momelotinib (Ojjaara)
Motixafortide (Aphexda)
N
Niraparib and abiraterone (Akeega)
Nirogacestat (Ogsiveo)
P
Pirtobrutinib (Jaypirca)
Q
Quizartinib (Vanflyta)
R
Repotrectinib (Augtyro)
Retifanlimab (Zynyz)
T
Talquetamab (Talvey)
Toripalimab (Loqtorzi)
U
Ublituximab (Briumvi)